Targeted drug delivery to macrophages
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Targeted drug delivery to the macrophages appears to be an attractive proposition to improve therapeutic efficacy of enclosed drug. Thus, macrophages can be exploited as Trojan horses for targeted drug delivery. Nanocarriers can migrate across the different membrane barriers and release their drug cargo at sites of infection. AREAS COVERED: This review discusses the current status and utilization of various micro- as well as nanocarriers like microspheres/microparticles, liposomes, nanoparticles, dendrimers, niosomes, and carbon nanotubes for targeted delivery of bioactives to the macrophages. EXPERT OPINION: The design of nanocarriers for cell-mediated drug delivery may differ from those used for conventional drug delivery systems. The literature review shows that nanocarriers could supplement sustained drug delivery to the macrophages, extended duration of action, reduced therapeutic dose, improved patient compliance, and reduced adverse effects of highly toxic, potent drugs. There is still a need to identify more specific receptors that are responsible for macrophage targeting. The identification of such receptors may also facilitate drug targeting to further specific parts of the body containing different types of macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“A dysregulated macrophage function is associated with a wide range of conditions including chronic ulcers, allergic asthma, atherosclerosis, autoimmune disorders, and fibrotic diseases [45].”
BackgroundStrategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Blanazs, A., Armes, S. P., & Ryan, A. J. (2009) · Macromolecular Rapid Communications · doi:10.1002/marc.200800713 · Cited by 1,500 · cited 1×
“Polymersomes, either degradable or non-degradable, with better stability and easier to modify as compared to liposomes have been explored for programmed delivery of hydrophobic and hydrophilic drugs [78-80].”
BackgroundAhsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570
Cell size of alveolar macrophages: an interspecies comparison.
Krombach, F., Münzing, S., Allmeling, A. M., Gerlach, J. T., Behr, J., & Dörger, M. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51261 · Cited by 285
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.011 · Cited by 164
Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting
Nimje, N., Agarwal, A., Saraogi, G. K., Lariya, N., Rai, G., Agrawal, H., & Agrawal, G. P. (2009) · Journal of Drug Targeting · doi:10.3109/10611860903115308 · Cited by 137 · cited 2×
“The authors concluded that mannoseconjugated SLNs can be exploited for effective and targeted delivery of rifabutin as compared to its uncoated formulation and ultimately increasing the therapeutic margin of safety while reducing free drug-associated side effects [48].”
BackgroundWattendorf, U., Coullerez, G., Vörös, J., Textor, M., & Merkle, H. P. (2008) · Langmuir · doi:10.1021/la801085d · Cited by 58
Cited by
Nanotechnologies in Food Science: Applications, Recent Trends, and Future Perspectives
Nile, S. H., Baskar, V., Selvaraj, D., Nile, A., Xiao, J., & Kai, G. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-0383-9 · Cited by 631
Nanocarriers for targeted drug delivery
Shah, A., Aftab, S., Nisar, J., Ashiq, M. N., & Iftikhar, F. J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102426 · Cited by 161
Metadata
- Authors
- Jain, N. K., Mishra, V., & Mehra, N. K.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-01-06
- Volume
- 10
- Issue
- 3
- Pages
- 353-367
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2035584686
- Cited by
- 183
- References
- 9
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeted drug delivery to macrophages. https://app.cochat.ai/papers/10.1517/17425247.2013.751370
- The paper
- Jain, N. K., Mishra, V., & Mehra, N. K. (2013). Targeted drug delivery to macrophages. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2013.751370
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.